You are here: Industry Insights > Market News > EU reaches supply deal with Moderna for 160 mn doses of COVID-19 vaccine

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Vibegron Intermediate CAS:1421271-01-3

Food Grade Fish Collagen

Vibegron Intermediate CAS:1295539-30-8

Vibegron Intermediate CAS:1426235-01-9

Vibegron Intermediate CAS:163625-46-5

Vibegron Intermediate

EU reaches supply deal with Moderna for 160 mn doses of COVID-19 vaccine

expresspharmaNovember 25, 2020

Tag: COVID-19 vaccine , EU , Moderna

Favorites

The European Commission (EU) has reached a deal with US biotech firm Moderna for the supply of its COVID-19 vaccine candidate, an EU official told Reuters.

The president of the EU, Ursula von der Leyen informed that the deal is for the supply of up to 160 million doses of its COVID-19 vaccine candidate.

The deal will be formally approved by the EU executive on Wednesday, she said.

Previous:AIOCD asks members to strengthen cold chain capabilities for COVID-19 vaccines

Next:Micro Labs launches anti-diabetic drug combo, Dapagliflozin plus Metformin

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

EU reaches supply deal with Moderna for 160 mn doses of COVID-19 vaccine | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

API, pharmaceutical intermediate, preparation, life science, in vitro diagnostic, liquid crystal, OL

Heraeus replacement PELC200/785A deuterium lamp

High Quality Pharmaceutical Grade Azelaic Acid CAS 123-99-9

Handhold Raman Spectrometers for pharmaceutical raw materials

Neutral Borosilicate Glass

H-Leu-OBzl.Tos

1-(2-Furoyl)piperazine other active pharmaceutical ingredients

dimethyl sulfoxide DMSO Pharmaceutical grade uses of dimethylsulfoxide

Rizatriptan benzoate ≥98.0% API Pharmaceutical made in china

Pneumatic ball valve size figure

EU reaches supply deal with Moderna for 160 mn doses of COVID-19 vaccine

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>